Despotov, Katalin
Zádori, Dénes
Veres, Gábor
Jakab, Katalin
Gárdián, Gabriella
Tóth, Eszter
Kincses, Tamás Zsigmond
Vécsei, László
Ajtay, András
Bereczki, Dániel
Klivényi, Péter
Funding for this research was provided by:
Hungarian Brain Research Program (2017-1.2.1-NKP-2017-00002 NAP VI/4)
University of Szeged Open Access Fund (4802)
Article History
Received: 3 July 2020
Accepted: 2 February 2021
First Online: 18 February 2021
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards, as well as approved by the Regional Human Biomedical Research Ethics Committee of the University of Szeged (registration number is 44/2016). Informed consent was obtained from all participants.
: Not applicable.
: Katalin Despotov received support for congress participation from TEVA, and speaker honoraria from Novartis. Dénes Zádori received < 1000 EUR honoraria for lectures, travel expenses and registration fees for conferences, educational grants from Hungarian subsidiaries of Abbvie, Abott, Allergan, Goodwill Pharma, Ipsen, Krka, Medis, Medtronic, Sandoz, TEVA and UCB. Regarding this study, the authors did not receive any corporate funding. Gábor Veres, Katalin Jakab, Gabriella Gárdián, Eszter Tóth, Tamás Zs Kincses, László Vécsei, András Ajtay, Dániel Bereczki, Péter Klivényi declare no conflict of interest.